Processa Pharmaceuticals, Inc.
PCSA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,437 | -$3,934 | -$2,834 | -$2,729 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $75 | $431 | $228 | $155 |
| Change in WC | -$375 | $1,437 | -$146 | $303 |
| Other Non-Cash | $252 | -$204 | $23 | $22 |
| Operating Cash Flow | -$3,484 | -$2,270 | -$2,730 | -$2,248 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$1 | -$2 | -$1 |
| Stock Issued | $2,860 | $6,320 | $4,439 | $549 |
| Stock Repurch. | $1 | $0 | -$1 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$9 | $0 | $0 |
| Financing Cash Flow | $2,856 | $6,310 | $4,436 | $548 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$628 | $4,040 | $1,706 | -$1,700 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,937 | $2,897 | $1,191 | $2,891 |
| End Cash | $6,308 | $6,937 | $2,897 | $1,191 |
| Free Cash Flow | -$3,484 | -$2,270 | -$2,730 | -$2,248 |